Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Uveitis, Anterior D014606 11 associated lipids
Migraine Disorders D008881 11 associated lipids
Shock D012769 11 associated lipids
Meningioma D008579 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Amnesia D000647 12 associated lipids
Hypertension, Portal D006975 12 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Fetal Weight D020567 12 associated lipids
Death, Sudden D003645 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Heart Arrest D006323 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Polycythemia Vera D011087 13 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Handa RK et al. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. 1991 Am. J. Physiol. pmid:1907104
Senn N and Garay RP Regulation of Na+ and K+ contents in rat thymocytes. 1989 Am. J. Physiol. pmid:2546433
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Rizzo A et al. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2. 1995 Am. J. Physiol. pmid:7771545
Olson NC et al. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs. 1993 Am. J. Physiol. pmid:8460710
Haller H et al. Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in human alveolar macrophages. 1991 Am. J. Physiol. pmid:1662920
Widdicombe JH et al. Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. 1989 Am. J. Physiol. pmid:2514604
McGowan HM et al. Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat. 1986 Am. J. Physiol. pmid:3538908
Olson NC et al. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. 1990 Am. J. Physiol. pmid:2163217
Gaboury JP et al. Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. 1994 Am. J. Physiol. pmid:7908174
Bosch RJ et al. Effects of parathyroid hormone-related protein on human mesangial cells in culture. 1999 Am. J. Physiol. pmid:10600786
Kubes P et al. Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. 1991 Am. J. Physiol. pmid:1647676
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Sasaki T et al. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland. 1989 Am. J. Physiol. pmid:2692465
Sirén AL and Feuerstein G Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. 1989 Am. J. Physiol. pmid:2546449
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Brock TA and Gimbrone MA Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells. 1986 Am. J. Physiol. pmid:3717361
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Kinnula VL et al. Release of reactive oxygen species by guinea pig tracheal epithelial cells in vitro. 1992 Am. J. Physiol. pmid:1616055
Gao Y et al. PAF induces relaxation of pulmonary arteries but contraction of pulmonary veins in the ferret. 1995 Am. J. Physiol. pmid:7653635
Wood JG et al. Gastric microvascular actions of platelet-activating factor: role of leukocytes. 1992 Am. J. Physiol. pmid:1550241
Conyers G et al. A factor in serum lowers resistance and opens tight junctions of MDCK cells. 1990 Am. J. Physiol. pmid:2221039
Badr KF et al. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. 1989 Am. J. Physiol. pmid:2912165
Kvietys PR et al. Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules. 1990 Am. J. Physiol. pmid:2221068
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Ferrer-Lopez P et al. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. 1990 Am. J. Physiol. pmid:2360620
Wallace JL et al. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. 1989 Am. J. Physiol. pmid:2650567
Handa RK et al. Platelet-activating factor is a renal vasodilator in the anesthetized rat. 1990 Am. J. Physiol. pmid:2360650
Kanwar S et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. 1994 Am. J. Physiol. pmid:8141295
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Perico N et al. Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. 1991 Am. J. Physiol. pmid:1713421
Wang J and Dunn MJ Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. 1987 Am. J. Physiol. pmid:2827506
Lang CH et al. Platelet-activating factor-induced increases in glucose kinetics. 1988 Am. J. Physiol. pmid:3348371
Kornecki E and Ehrlich YH Diminished responsiveness of human platelets to platelet-activating factor during pregnancy. 1990 Am. J. Physiol. pmid:2396687
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Bradley LM et al. Circulatory effects of PAF-acether in newborn piglets. 1989 Am. J. Physiol. pmid:2912183
Dobrowsky RT et al. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. 1991 Am. J. Physiol. pmid:2035668
Chang SW et al. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. 1989 Am. J. Physiol. pmid:2801951
Mózes T et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. 1989 Am. J. Physiol. pmid:2802004
Hines KL et al. PAF increases hepatic vascular resistance and glycogenolysis in vivo. 1991 Am. J. Physiol. pmid:1848410
Stahl GL et al. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. 1997 Am. J. Physiol. pmid:9227410
Kubes P et al. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. 1990 Am. J. Physiol. pmid:2301577
Chang SW et al. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury. 1990 Am. J. Physiol. pmid:2301603
Pique JM et al. Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF. 1990 Am. J. Physiol. pmid:2316650
Martins MA et al. Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. 1991 Am. J. Physiol. pmid:1722649
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Johnson A et al. Tumor necrosis factor-alpha primes pulmonary hemodynamic response to N-formyl-L-methionyl-L-leucyl-L-phenylalanine. 1991 Am. J. Physiol. pmid:1656789